Literature DB >> 2462061

A mutation in v-src that removes a single conserved residue in the SH-2 domain of pp60v-src restricts transformation in a host-dependent manner.

M F Verderame1, J M Kaplan, H E Varmus.   

Abstract

The v-src oncogene of Rous sarcoma virus (RSV) is able to transform both avian and mammalian cells, but the mutant allele v-src-L displays a host range dependence for transformation, transforming chicken but not rat cells with wild-type efficiency. This host range restriction can be detected by measuring growth in low serum, saturation density, and anchorage independent growth. In addition, rat cells expressing v-src-L do not form tumors in syngeneic rats or nude mice, but RSV carrying the mutant allele causes tumors in chicks, although at a reduced efficiency and with increased latency. To determine the lesion responsible for this phenotype, we sequenced the entire v-src gene from the parental B77 strain of RSV, as well as the mutant allele. v-src-L is missing 3 nucleotides present in the wild-type parent, RSV B31, eliminating Phe-172, an invariant residue in a conserved region of src-related proteins known as SH-2. The kinase activity of pp60v-src-L was indistinguishable from that of the wild type in chicken cells but was significantly reduced in rat cells as assayed by an in vitro immune complex assay; in vivo phosphorylation of one specific substrate, p36 (calpactin I heavy chain); and total phosphotyrosine-containing proteins. In addition, the pattern of phosphotyrosine-containing proteins in rat cells was qualitatively different when cells containing pp60v-src-L were compared with cells with wild-type pp60v-src, even though both pp60v-src proteins were membrane associated. The data are consistent with a role for the SH-2 region in substrate specificity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2462061      PMCID: PMC247689     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Revertants of an ASV-transformed rat cell line have lost the complete provius or sustained mutations in src.

Authors:  H E Varmus; N Quintrell; J Wyke
Journal:  Virology       Date:  1981-01-15       Impact factor: 3.616

2.  Nucleotide sequence of Rous sarcoma virus.

Authors:  D E Schwartz; R Tizard; W Gilbert
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

3.  Frameshift and intragenic suppressor mutations in a Rous sarcoma provirus suggest src encodes two proteins.

Authors:  G Mardon; H E Varmus
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

Review 4.  Regulation of cell growth and transformation by tyrosine-specific protein kinases: the search for important cellular substrate proteins.

Authors:  J A Cooper; T Hunter
Journal:  Curr Top Microbiol Immunol       Date:  1983       Impact factor: 4.291

5.  Expression of v-src and chicken c-src in rat cells demonstrates qualitative differences between pp60v-src and pp60c-src.

Authors:  R C Parker; H E Varmus; J M Bishop
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

6.  Structure and sequence of the cellular gene homologous to the RSV src gene and the mechanism for generating the transforming virus.

Authors:  T Takeya; H Hanafusa
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

7.  Phosphotyrosyl-protein phosphatase of TCRC-2 cells.

Authors:  G Swarup; K V Speeg; S Cohen; D L Garbers
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

8.  Hormonal regulation of the Rous sarcoma virus src gene via a heterologous promoter defines a threshold dose for cellular transformation.

Authors:  E B Jakobovits; J E Majors; H E Varmus
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

9.  Phosphorylation sites in enolase and lactate dehydrogenase utilized by tyrosine protein kinases in vivo and in vitro.

Authors:  J A Cooper; F S Esch; S S Taylor; T Hunter
Journal:  J Biol Chem       Date:  1984-06-25       Impact factor: 5.157

10.  Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses.

Authors:  L A Lipsich; A J Lewis; J S Brugge
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

View more
  29 in total

1.  Src homology region 2 domains direct protein-protein interactions in signal transduction.

Authors:  M F Moran; C A Koch; D Anderson; C Ellis; L England; G S Martin; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo.

Authors:  B J Mayer; P K Jackson; R A Van Etten; D Baltimore
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

3.  Multiple SH2-mediated interactions in v-src-transformed cells.

Authors:  C A Koch; M F Moran; D Anderson; X Q Liu; G Mbamalu; T Pawson
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

Review 4.  The discovery of modular binding domains: building blocks of cell signalling.

Authors:  Bruce J Mayer
Journal:  Nat Rev Mol Cell Biol       Date:  2015-09-30       Impact factor: 94.444

5.  The common src homology region 2 domain of cytoplasmic signaling proteins is a positive effector of v-fps tyrosine kinase function.

Authors:  C A Koch; M Moran; I Sadowski; T Pawson
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

6.  Transformation by pp60src or stimulation of cells with epidermal growth factor induces the stable association of tyrosine-phosphorylated cellular proteins with GTPase-activating protein.

Authors:  A H Bouton; S B Kanner; R R Vines; H C Wang; J B Gibbs; J T Parsons
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

7.  Src homology domains of v-Src stabilize an active conformation of the tyrosine kinase catalytic domain.

Authors:  B Xu; W T Miller
Journal:  Mol Cell Biochem       Date:  1996-05-10       Impact factor: 3.396

8.  Site-directed mutagenesis of the SH2- and SH3-coding domains of c-src produces varied phenotypes, including oncogenic activation of p60c-src.

Authors:  H Hirai; H E Varmus
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

9.  Effects of SH2 and SH3 deletions on the functional activities of wild-type and transforming variants of c-Src.

Authors:  C Seidel-Dugan; B E Meyer; S M Thomas; J S Brugge
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

10.  The membrane-binding domain of the Rous sarcoma virus Gag protein.

Authors:  M F Verderame; T D Nelle; J W Wills
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.